# Bairuiqi Biology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bairuiqi-biology

- Industry: Biotechnology
- Headquarters: Beijing, China
- Latest round: Series A (Mar 20, 2017)
- Investors on record: 2

## About

Established in 2013 and based in Beijing, China, Bairuiqi Biology is a monoclonal antibody developer. In December 2017, it closed a series B funding from returning investor Haoyue Capital. 

The company mainly develops monoclonal antibodies and provides users with solutions for the treatment of fibrotic diseases.

The company generates revenue by providing monoclonal antibody and solution of treating fibrosis for patients.

## Funding rounds

- Series A, Mar 20, 2017 — Legend Star, Haoyue Capital

## Investors

- Legend Star (https://capitalatlas.ai/funds/legend-star) — Series A
- Haoyue Capital (https://capitalatlas.ai/funds/haoyue-capital) — Series A